VXRT News and Press, Vaxart Inc. From 07/27/20

WISeKey International WKEY  -20% . More news on: Vaxart, Inc., PolarityTE, Inc., Sunworks, Inc., Stocks on the move, , Read more ...

Many companies' business prospects have been hurt as a result of the COVID-19 pandemic. Lockdowns and general public wariness about being infected by the novel coronavirus have taken a toll. But there are also some companies that have seen their business prospects soar due to the viral outbreak ...

Robinhood investors are known for their capricious and sometimes idiosyncratic trading activity, but it would be folly to discount their growing effect on the price of small-cap stocks. Especially for nascent or clinical-stage biotech companies without any products approved for sale, a spurt of ...

Rather than wowing speculators with promises of a scientific breakthrough, Emergent BioSolutions ' (NYSE: EBS) coronavirus strategy positions the company as the go-to resource for vaccine manufacturing support. Aside from its ever-increasing number of contract manufacturing agreements with ma...

Investors sold off shares of several coronavirus vaccine-related stocks on Friday as lawmakers ramp up pressure on drugmakers. By the close of trading, shares of Vaxart (NASDAQ: VXRT) , Inovio Pharmaceuticals (NASDAQ: INO) , BioNTech (NASDAQ: BNTX) , and Moderna (NASDAQ: MRNA) we...

Many big drugmakers launched programs earlier this year to fight COVID-19. But the biggest winners for investors have been the stocks of small coronavirus-focused biotechs. Two that particularly stand out are  Sorrento Therapeutics (NASDAQ: SRNE) and  Vaxart (NASDAQ: VXRT) . Sorr...

With the coronavirus pandemic gripping the world, governments everywhere are desperate to speed up the discovery of a vaccine. In the U.S., since May, this dire need has been addressed by a vaccine accelerator project called Operation Warp Speed (OWS), which subsidizes public and private compani...

NetworkNewsWire Editorial Coverage : Effective pandemic response relies first and foremost on fast and accurate testing to buy time and save lives while therapeutics and vaccines are developed. Coronavirus cases continued to surge in the US this month, showing no signs of slowing since lock...

The world is desperate for a COVID-19 vaccine. The U.S. government is giving away billions of dollars in grant money in the hopes that somebody, anybody, will find a vaccine that works and will defeat this awful disease. And so far, anyway, investors in this sector have done well. In the first ...

You could play it safe. Put your money in assets that aren't likely to lose their value. Maybe you might opt to buy shares of utility companies that enjoy monopolies.  But not every investor wants to take the safe path that leads to smaller returns over the long run. Even normally risk-ave...